FDA Takes Cautious Approach to Avastin as Metastatic Breast Cancer Treatment

By PJ Hamel, Health Guide Sunday, December 09, 2007

- A
- A
- A

When the news broke December 5 that an FDA expert panel had voted 5-4 to reject Avastin (bevacizumab) as an approved breast cancer treatment because of serious side effects, I experienced a moment of deep sadness, as well as some frustration. Avastin, a cutting-edge, “targeted drug” thera...

Read the rest of this post >>

Surviving Breast Cancer: Putting Your Emotions to the Test

Hide Comments | Add comment

Jeane

12/13/07 12:14am

Hi PJ,

I thought you might find this interesting.

http://www.medicalnewstoday.com/articles/91556.php

Related Breast Cancer Topics

By PJ Hamel, Health Guide— Last Modified: 03/05/11, First Published: 12/09/07

Note: All clinical content on this site is physician-reviewed, except material generated by our community members.

Featuring Content From:

We comply with the HONcode standard for
trustworthy health information: verify here.

By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.

Healthcentral.com is part of Remedy Health Media

FDA Takes Cautious Approach to Avastin as Metastatic Breast Cancer Treatment

Ask a Question